Strontium in the Bone-Implant Interface

Danish Medical Bulletin

Volumn 58, Issue 5, 2011, Pages

  Vestermark, Marianne Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYAPATITE; STRONTIUM; STRONTIUM MALONATE; STRONTIUM RANELATE; UNCLASSIFIED DRUG; BIOACTIVE GLASS 45S5; BIOMATERIAL; GLASS;

ALLOGRAFT; ARTICLE; BIOLOGY; BIOMECHANICS; BONE ALLOGRAFT; BONE CELL; BONE GRAFT; BONE MASS; BONE REGENERATION; BONE TISSUE; DRUG ABSORPTION; DRUG ELIMINATION; ENERGY ABSORPTION; EXPERIMENTAL MODEL; FRACTURE HEALING; HIP ARTHROPLASTY; HIP SURGERY; HUMAN; IMPLANT; MORPHOMETRICS; NONHUMAN; OBSERVER VARIATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PROSTHESIS LOOSENING; SHEAR STRENGTH; STEREOLOGY; TOTAL HIP PROSTHESIS; ANIMAL; BONE TRANSPLANTATION; DOG; DRUG EFFECT; HIP PROSTHESIS; METHODOLOGY; PROSTHESIS FAILURE; REVIEW;

ANIMALS; BONE TRANSPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; DOGS; GLASS; HIP PROSTHESIS; HUMANS; HYDROXYAPATITES; OSSEOINTEGRATION; PROSTHESIS FAILURE; STRONTIUM;

EID: 79955960948     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (158)

1. Pedersen AB, Johnsen SP, Overgaard S, Soballe K, SorensenHT, Lucht U. Total hip arthroplasty in Denmark: incidence ofprimary operations and revisions during 1996-2002 and estimatedfuture demands. Acta Orthop 2005;76:182-9.
2. Lie SA, Havelin LI, Furnes ON, Engesaeter LB, Vollset SE. Failurerates for 4762 revision total hip arthroplasties in the NorwegianArthroplasty Register. JBone Joint SurgBr 2004;86:504-9.
3. Pilliar RM, Lee JM, Maniatopoulos C. Observations on theeffect of movement on bone ingrowth into porous-surfacedimplants. ClinOrthopRelat Res 1986:108-13.
4. Karrholm J, Borssen B, Lowenhielm G, Snorrason F. Does earlymicromotion of femoral stem prostheses matter? 4-7-yearstereoradiographic follow-up of 84 cemented prostheses. JBoneJoint SurgBr 1994;76:912-7.
5. Bauer TW, Schils J. The pathology of total joint arthroplasty.II.Mechanisms of implant failure. Skeletal Radiol 1999;28:483-97.
6. Murray DW, Rushton N. Macrophages stimulate boneresorption when they phagocytose particles. J Bone Joint Surg Br 1990;72:988-92.
7. Cooper RA, McAllister CM, Borden LS, Bauer TW. Polyethylenedebris-induced osteolysis and loosening in uncemented total hiparthroplasty. A cause of late failure. J Arthroplasty 1992;7:285-90.
8. Rahbek O, Overgaard S, Lind M, Bendix K, Bunger C, Soballe K.Sealing effect of hydroxyapatite coating on peri-implant migrationof particles. An experimental study in dogs. J Bone Joint Surg Br 2001;83:441-7.
9. Branemark PI, Hansson BO, Adell R, Breine U, Lindstrom J, Hallen O, et al. Osseointegrated implants in the treatment of theedentulous jaw. Experience from a 10-year period. Scand J PlastReconstr Surg Suppl 1977;16:1-132.
10. Albrektsson T, Branemark PI, Hansson HA, Lindstrom J. Osseointegrated titanium implants. Requirements for ensuring along-lasting, direct bone-to-implant anchorage in man. ActaOrthop Scand 1981;52:155-70.
11. Zarb GA, Alberktsson T. [Criteria for determining clinicalsuccess with osseointegrated dental implants]. Cah Prothese 1990:19-26.
12. Soballe K, Hansen ES, Brockstedt-Rasmussen H, Pedersen CM, Bunger C. Hydroxyapatite coating enhances fixation ofporous coated implants. A comparison in dogs between press fitand noninterference fit. Acta OrthopScand 1990;61:299-306.
13. Wanpeng C, Hench LL. 1996. p. 493-507.
14. Albrektsson T, Johansson C. Osteoinduction, osteoconductionand osseointegration. EurSpine J 2001;10 Suppl 2:S96-101.
15. Havelin LI, Fenstad AM, Salomonsson R, Mehnert F, Furnes O, Overgaard S, et al. The Nordic Arthroplasty Register Association: aunique collaboration between 3 national hip arthroplastyregistries with 280,201 THRs. Acta Orthop 2009;80:393-401.
16. Karrholm J, Snorrason F. Subsidence, tip, and humpmicromovements of noncoated ribbed femoral prostheses. ClinOrthopRelat Res 1993:50-60.
17. Baas J, Elmengaard B, Jakobsen T, Bechtold J, Soballe K. CrackRevision Improves Fixation of Uncemented HA-coated ImplantsCompared with Reaming: An Experiment in Dogs. Clin Orthop Relat Res 2009.
18. Xie XH, Yu XW, Zeng SX, Du RL, Hu YH, Yuan Z, et al. Enhanced osteointegration of orthopaedic implant gradientcoating composed of bioactive glass and nanohydroxyapatite. J Mater Sci Mater Med 2010.
19. Kienapfel H, Sprey C, Wilke A, Griss P. Implant fixation bybone ingrowth. J Arthroplasty 1999;14:355-68.
20. McKibbin B. The biology of fracture healing in long bones. J Bone Joint Surg Br 1978;60-B:150-62.
21. Cruess RL, Dumont J. Fracture healing. Can J Surg 1975;18:403-13.
22. Frost HM. The biology of fracture healing. An overview forclinicians. Part II. Clin Orthop Relat Res 1989:294-309.
23. Einhorn TA. The cell and molecular biology of fracturehealing. Clin Orthop Relat Res 1998:S7-21.
24. Jakobsen T, Baas J, Kold S, Bechtold JE, Elmengaard B, Soballe K. Local bisphosphonate treatment increases fixation ofhydroxyapatite-coated implants inserted with bone compaction. J Orthop Res 2009;27:189-94.
25. Dhert WJ, Thomsen P, Blomgren AK, Esposito M, Ericson LE, Verbout AJ. Integration of press-fit implants in cortical bone: astudy on interface kinetics. J Biomed Mater Res 1998;41:574-83.
26. Branemark R, Ohrnell LO, Nilsson P, Thomsen P. Biomechanical characterization of osseointegration duringhealing: an experimental in vivo study in the rat. Biomaterials 1997;18:969-78.
27. Kold S, Rahbek O, Vestermark M, Overgaard S, Soballe K. Bone compaction enhances fixation of weightbearing titaniumimplants. Clin Orthop Relat Res 2005:138-44.
28. Turner CH. On Wolff's law of trabecular architecture. JBiomech 1992;25:1-9.
29. Frost HM. A 2003 update of bone physiology and Wolff's Lawfor clinicians. Angle Orthod 2004;74:3-15.
30. Elkouri ER. Review of cancellous and cortical bone healingafter fracture or osteotomy. J Am Podiatry Assoc 1982;72:464-6.
31. Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN. Bone-graft substitutes: facts, fictions, andapplications. J Bone Joint Surg Am 2001; 83-A Suppl 2 Pt 2:98-103.
32. LeGeros RZ. Properties of osteoconductive biomaterials:calcium phosphates. ClinOrthopRelat Res 2002:81-98.
33. de Groot K, Geesink R, Klein CP, Serekian P. Plasma sprayedcoatings of hydroxylapatite. J Biomed Mater Res 1987;21:1375-81.
34. Wilson J, Low SB. Bioactive ceramics for periodontaltreatment: comparative studies in the Patus monkey. J Appl Biomater 1992;3:123-9.
35. Bigi AMF; Ripamonti, A; Roveri, N;. Magnisium andStrontium Interaction with Carbonate-Containing Hydroxyapatitein Aqueous Medium. Journal of Inorganic Biochemistry 1981;15.
36. Bertoni E, Bigi A, Cojazzi G, Gandolfi M, Panzavolta S, Roveri N. Nanocrystals of magnesium and fluoride substitutedhydroxyapatite. J Inorg Biochem 1998;72:29-35.
37. Overgaard S. Calcium phosphate coatings for fixation of boneimplants: Evaluated mechanically and histologically bystereological methods. Acta Orthopaedica 2000;71:74.
38. LeGeros RZ. Biodegradation and bioresorption of calciumphosphate ceramics. ClinMater 1993;14:65-88.
39. Verdonschot N, van Hal CT, Schreurs BW, Buma P, Huiskes R, Slooff TJ. Time-dependent mechanical properties of HA/TCPparticles in relation to morsellized bone grafts for use inimpaction grafting. J Biomed Mater Res 2001;58:599-604.
40. Jensen TB, Overgaard S, Lind M, Rahbek O, Bunger C, Soballe K. Osteogenic protein-1 increases the fixation of implants graftedwith morcellised bone allograft and ProOsteon bone substitute:an experimental study in dogs. J Bone Joint Surg Br 2007;89:121-6.
41. Baas J, Elmengaard B, Bechtold J, Chen X, Soballe K. Ceramicbone graft substitute with equine bone protein extract iscomparable to allograft in terms of implant fixation: a study indogs. Acta Orthop 2008;79:841-50.
42. Thomas KA. Hydroxyapatite coatings. Orthopedics 1994;17:267-78.
43. Soballe K. Hydroxyapatite ceramic coating for bone implantfixation. Mechanical and histological studies in dogs. ActaOrthopScandSuppl 1993;255:1-58.
44. Dorozhkin SV. Amorphous calcium (ortho)phosphates. ActaBiomater 2010.
45. Soballe K, Overgaard S. The current status of hydroxyapatitecoating of prostheses. J Bone Joint Surg Br 1996;78:689-91.
46. Overgaard S, Lind M, Rahbek O, Bunger C, Soballe K. Improved fixation of porous-coated versus grit-blasted surfacetexture of hydroxyapatite-coated implants in dogs. Acta OrthopScand 1997;68:337-43.
47. Gledhill HC, Turner IG, Doyle C. Direct morphologicalcomparison of vacuum plasma sprayed and detonation gunsprayed hydroxyapatite coatings for orthopaedic applications. Biomaterials 1999;20:315-22.
48. Rossler S, Sewing A, Stolzel M, Born R, Scharnweber D, Dard M, et al. Electrochemically assisted deposition of thin calciumphosphate coatings at near-physiological pH and temperature. JBiomed Mater Res A 2003;64:655-63.
49. Soballe K, Toksvig-Larsen S, Gelineck J, Fruensgaard S, Hansen ES, Ryd L, et al. Migration of hydroxyapatite coatedfemoral prostheses. A Roentgen Stereophotogrammetric study. JBone Joint Surg Br 1993;75:681-7.
50. Geesink RG, Hoefnagels NH. Six-year results ofhydroxyapatite-coated total hip replacement. J Bone Joint Surg Br 1995;77:534-47.
51. Paulsen A, Pedersen AB, Johnsen SP, Riis A, Lucht U, Overgaard S. Effect of hydroxyapatite coating on risk of revisionafter primary total hip arthroplasty in younger patients: findingsfrom the Danish Hip Arthroplasty Registry. Acta Orthop 2007;78:622-8.
52. Soballe K. Hydroxyapatite ceramic coating for bone implantfixation. Mechanical and histological studies in dogs. Acta OrthopScand Suppl 1993;255:1-58.
53. Soballe K, Hansen ES, H BR, Jorgensen PH, Bunger C. Tissueingrowth into titanium and hydroxyapatite-coated implantsduring stable and unstable mechanical conditions. J Orthop Res 1992;10:285-99.
54. Daugaard H, Elmengaard B, Bechtold JE, Jensen T, Soballe K. The effect on bone growth enhancement of implant coatings withhydroxyapatite and collagen deposited electrochemically and byplasma spray. J Biomed Mater Res A 2010;92:913-21.
55. Tian M, Chen F, Song W, Song Y, Chen Y, Wan C, et al. In vivostudy of porous strontium-doped calcium polyphosphatescaffolds for bone substitute applications. JMaterSciMaterMed 2009;20:1505-12.
56. Grynpas M. Age and disease-related changes in the mineralof bone. Calcif Tissue Int 1993;53 Suppl 1:S57-64.
57. Li ZY, Lam WM, Yang C, Xu B, Ni GX, Abbah SA, et al. Chemicalcomposition, crystal size and lattice structural changes afterincorporation of strontium into biomimetic apatite. Biomaterials 2007;28:1452-60.
58. Christoffersen J, Christoffersen MR, Kolthoff N, Barenholdt O. Effects of strontium ions on growth and dissolution ofhydroxyapatite and on bone mineral detection. Bone 1997;20:47-54
59. Hench LL, Wilson J. Surface-active biomaterials. Science 1984;226:630-6.
60. Hench LL, Xynos ID, Polak JM. Bioactive glasses for in situtissue regeneration. JBiomaterSciPolymEd 2004;15:543-62.
61. Oonishi H, Hench LL, Wilson J, Sugihara F, Tsuji E, Kushitani S, et al. Comparative bone growth behavior in granules ofbioceramic materials of various sizes. JBiomedMaterRes 1999;44:31-43.
62. Oonishi H, Kushitani S, Yasukawa E, Iwaki H, Hench LL, Wilson J, et al. Particulate bioglass compared with hydroxyapatite as abone graft substitute. ClinOrthopRelat Res 1997:316-25.
63. Thomas MV, Puleo DA, Al-Sabbagh M. Bioactive glass threedecades on. JLongTermEffMedImplants 2005;15:585-97.
64. Gao T, Aro HT, Ylanen H, Vuorio E. Silica-based bioactiveglasses modulate expression of bone morphogenetic protein-2mRNA in Saos-2 osteoblasts in vitro. Biomaterials 2001;22:1475-83.
65. Abou Neel EA, Chrzanowski W, Pickup DM, O'Dell LA, Mordan NJ, Newport RJ, et al. Structure and properties of strontiumdopedphosphate-based glasses. JRSocInterface 2009;6:435-46.
66. Rosenberg ES, Fox GK, Cohen C. Bioactive glass granules forregeneration of human periodontal defects. JEsthetDent 2000;12:248-57.
67. Schepers EJ, Ducheyne P, Barbier L, Schepers S. Bioactiveglass particles of narrow size range: a new material for the repairof bone defects. ImplantDent 1993;2:151-6.
68. Pazo A, Saiz E, Tomsia AP. Silicate glass coating on Ti-basedimplants. Acta Materialia 1998;46:2551-8.
69. Lotfibakhshaiesh N, Brauer DS, Hill RG. Bioactive glassengineered coatings for Ti6Al4V alloys: Influence of strontiumsubstitution for calcium on sintering behaviour. Journal of Non-Crystalline Solids; 2009.
70. Clarkin O, Boyd D, Towler MR. Strontium-based GlassPolyalkenoate Cements for Luting Applications in the Skeleton. J Biomater Appl 2008.
71. Wren A, Boyd D, Towler MR. The processing, mechanicalproperties and bioactivity of strontium based glass polyalkenoatecements. J Mater Sci Mater Med 2008;19:1737-43.
72. Boyd D, Towler MR, Law RV, Hill RG. An investigation into thestructure and reactivity of calcium-zinc-silicate ionomer glassesusing MAS-NMR spectroscopy. JMaterSciMaterMed 2006;17:397-402.
73. Hill R, Er. An alternative view of the degradation of bioglass. Journal of Material Science Letters 1996;15:1122-5.
74. Hastings DE, Parker SM. Protrusio acetabuli in rheumatoidarthritis. Clin Orthop Relat Res 1975:76-83.
75. Burchardt H. The biology of bone graft repair. Clin Orthop Relat Res 1983:28-42.
76. Sherk HH, Nicholson JT. Fracture healing and the allograftreaction. Clin Orthop Relat Res 1971;76:94-9.
77. Goldberg VM, Stevenson S. Natural history of autografts andallografts. Clin Orthop Relat Res 1987:7-16.
78. Toms AD, Barker RL, Jones RS, Kuiper JH. Impaction bonegraftingin revision joint replacement surgery. J Bone Joint SurgAm 2004;86-A:2050-60.
79. Aspenberg P, Astrand J. Bone allografts pretreated with abisphosphonate are not resorbed. Acta OrthopScand 2002;73:20-3.
80. Baas J, Elmengaard B, Jensen TB, Jakobsen T, Andersen NT, Soballe K. The effect of pretreating morselized allograft bone withrhBMP-2 and/or pamidronate on the fixation of porous Ti and HAcoatedimplants. Biomaterials 2008;29:2915-22.
81. Jakobsen T, Baas J, Bechtold JE, Elmengaard B, Soballe K. Soaking morselized allograft in bisphosphonate can impairimplant fixation. ClinOrthopRelat Res 2007;463:195-201.
82. Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, et al. An uncoupling agent containing strontiumprevents bone loss by depressing bone resorption andmaintaining bone formation in estrogen-deficient rats. J BoneMiner Res 1993;8:607-15.
83. Pors Nielsen S. The Biological role of Strontium. Bone 2004;35:583-8.
84. Bauer GC, Wendeberg B. External counting of Ca47 and Sr85in studies of localised skeletal lesions in man. J Bone Joint Surg Br 1959;41-B:558-80.
85. Cabrera WE, Schrooten I, De Broe ME, D'Haese PC. Strontiumand bone. JBone MinerRes 1999;14:661-8.
86. Boivin G, Deloffre P, Perrat B, Panczer G, Boudeulle M, Mauras Y, et al. Strontium distribution and interactions with bonemineral in monkey iliac bone after strontium salt (S 12911)administration. J Bone Miner Res 1996;11:1302-11.
87. Marie PJ. Effective doses for strontium ranelate. OsteoporosInt 2008;19:1813; author reply 5-7.
88. Leeuwenkamp OR, van der Vijgh WJ, Husken BC, Lips P, Netelenbos JC. Human pharmacokinetics of orally administeredstrontium. Calcif Tissue Int 1990;47:136-41.
89. Aerssens J, Boonen S, Lowet G, Dequeker J. Interspeciesdifferences in bone composition, density, and quality: potentialimplications for in vivo bone research. Endocrinology 1998;139:663-70.
90. Raffalt AC, Andersen JE, Christgau S. Application ofinductively coupled plasma-mass spectrometry (ICP-MS) andquality assurance to study the incorporation of strontium intobone, bone marrow, and teeth of dogs after one month oftreatment with strontium malonate. AnalBioanalChem 2008;391:2199-207.
91. Brennan TC, Rybchyn MS, Green W, Atwa S, Conigrave AD, Mason RS. Osteoblasts play key roles in the mechanisms of actionof strontium ranelate. BrJPharmacol 2009;157:1291-300.
92. Fromigue O, Hay E, Barbara A, Petrel C, Traiffort E, Ruat M, et al. Calcium sensing receptor-dependent and -independentactivation of osteoblast replication and survival by strontiumranelate. J Cell Mol Med 2009.
93. Caverzasio J. Strontium ranelate promotes osteoblastic cellreplication through at least two different mechanisms. Bone 2008;42:1131-6.
94. Atkins GJ, Welldon KJ, Halbout P, Findlay DM. Strontiumranelate treatment of human primary osteoblasts promotes anosteocyte-like phenotype while eliciting an osteoprotegerinresponse. OsteoporosInt 2009;20:653-64.
95. Yamaguchi T. The calcium-sensing receptor in bone. JBoneMinerMetab 2008;26:301-11.
96. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289:1504-8.
97. Hurtel-Lemaire AS, Mentaverri R, Caudrillier A, Cournarie F, Wattel A, Kamel S, et al. The calcium-sensing receptor is involvedin strontium ranelate-induced osteoclast apoptosis. New insightsinto the associated signaling pathways. JBiolChem 2009;284:575-84.
98. Bonnelye E, Chabadel A, Saltel F, Jurdic P. Dual effect ofstrontium ranelate: stimulation of osteoblast differentiation andinhibition of osteoclast formation and resorption in vitro. Bone 2008;42:129-38.
99. Buehler J, Chappuis P, Saffar JL, Tsouderos Y, Vignery A. Strontium ranelate inhibits bone resorption while maintainingbone formation in alveolar bone in monkeys (Macaca fascicularis). Bone 2001;29:176-9.
100. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ. Thedivalent strontium salt S12911 enhances bone cell replication andbone formation in vitro. Bone 1996;18:517-23.
101. Takahashi N, Sasaki T, Tsouderos Y, Suda T. S 12911-2inhibits osteoclastic bone resorption in vitro. JBone MinerRes 2003;18:1082-7.
102. Dahl SG, Allain P, Marie PJ, Mauras Y, Boivin G, Ammann P, et al. Incorporation and distribution of strontium in bone. Bone 2001;28:446-53.
103. Farlay D, Boivin G, Panczer G, Lalande A, Meunier PJ. Longtermstrontium ranelate administration in monkeys preservescharacteristics of bone mineral crystals and degree ofmineralization of bone. J Bone Miner Res 2005;20:1569-78.
104. Grynpas MD, Marie PJ. Effects of low doses of strontium onbone quality and quantity in rats. Bone 1990;11:313-9.
105. Arlot ME, Jiang Y, Genant HK, Zhao J, Burt-Pichat B, Roux JP, et al. Histomorphometric and mu-CT Analysis of Bone Biopsiesfrom Postmenopausal Osteoporotic Women Treated withStrontium Ranelate. JBone MinerRes 2007.
106. Grynpas MD, Hamilton E, Cheung R, Tsouderos Y, Deloffre P, Hott M, et al. Strontium increases vertebral bone volume in ratsat a low dose that does not induce detectable mineralizationdefect. Bone 1996;18:253-9.
107. Ammann P, Shen V, Robin B, Mauras Y, Bonjour JP, Rizzoli R. Strontium ranelate improves bone resistance by increasing bonemass and improving architecture in intact female rats. JBoneMinerRes 2004;19:2012-20.
108. Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, et al. Strontium ranelate reduces therisk of nonvertebral fractures in postmenopausal women withosteoporosis: Treatment of Peripheral Osteoporosis (TROPOS)study. JClinEndocrinolMetab 2005;90:2816-22.
109. Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, et al. Effects of long-term strontium ranelatetreatment on the risk of nonvertebral and vertebral fractures inpostmenopausal osteoporosis: Results of a five-year, randomized,placebo-controlled trial. Arthritis Rheum 2008;58:1687-95.
110. O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY. Strontium ranelate for preventing and treating postmenopausalosteoporosis. CochraneDatabaseSystRev 2006:CD005326.
111. Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, et al. Effects of long-term strontium ranelatetreatment on vertebral fracture risk in postmenopausal womenwith osteoporosis. Osteoporos Int 2009;20:1663-73.
112. Park JW, Kim HK, Kim YJ, Jang JH, Song H, Hanawa T. Osteoblast response and osseointegration of a Ti-6Al-4V alloyimplant incorporating strontium. Acta Biomater 2010;6:2843-51.
113. Maimoun L, Brennan TC, Badoud I, Dubois-Ferriere V, RizzoliR, Ammann P. Strontium ranelate improves implantosseointegration. Bone 2010;46:1436-41.
114. Gorustovich AA, Steimetz T, Cabrini RL, Porto Lopez JM. Osteoconductivity of strontium-doped bioactive glass particles: Ahistomorphometric study in rats. J Biomed Mater Res A 2009.
115. Boyd D, Carroll G, Towler MR, Freeman C, Farthing P, Brook IM. Preliminary investigation of novel bone graft substitutesbased on strontium-calcium-zinc-silicate glasses. JMaterSciMaterMed 2009;20:413-20.
116. Towler MR, Boyd D, Freeman C, Brook IM, Farthing P. Comparison of in vitro and in vivo bioactivity of SrO-CaO-ZnOSiO2glass grafts. JBiomaterAppl 2009;23:561-72.
117. O'Loughlin PF, Morr S, Bogunovic L, Kim AD, Park B, Lane JM. Selection and development of preclinical models in fracturehealingresearch. J Bone Joint Surg Am 2008;90 Suppl 1:79-84.
118. Vestermark MT, Bechtold JE, Swider P, Soballe K. Mechanical interface conditions affect morphology and cellularactivity of sclerotic bone rims forming around experimentalloaded implants. JOrthopRes 2004;22:647-52.
119. Frost HM. The biology of fracture healing. An overview forclinicians. Part I. Clin Orthop Relat Res 1989:283-93.
120. Kirkwood. Essentials of Medical Statistics. 1st ed: BlackwellScience; 1988.
121. Jakobsen T, Kold S, Bechtold JE, Elmengaard B, Soballe K. Local alendronate increases fixation of implants inserted withbone compaction: 12-week canine study. JOrthopRes 2007;25:432-41.
122. Baas J, Lamberg A, Jensen TB, Elmengaard B, Soballe K. Thebovine bone protein lyophilisate Colloss improves fixation ofallografted implants--an experimental study in dogs. Acta Orthop 2006;77:791-8.
123. Shaw JA, Wilson SC, Bruno A, Paul EM. Comparison ofprimate and canine models for bone ingrowth experimentation,with reference to the effect of ovarian function on bone ingrowthpotential. J Orthop Res 1994;12:268-73.
124. Eitel F, Klapp F, Jacobson W, Schweiberer L. Boneregeneration in animals and in man. A contribution tounderstanding the relative value of animal experiments to humanpathophysiology. Arch Orthop Trauma Surg 1981;99:59-64.
125. Kimmel DB, Jee WS. A quantitative histologic study of boneturnover in young adult beagles. Anat Rec 1982;203:31-45.
126. Thomsen JS, Morukov BV, Vico L, Alexandre C, Saparin PI, Gowin W. Cancellous bone structure of iliac crest biopsiesfollowing 370 days of head-down bed rest. Aviat Space EnvironMed 2005;76:915-22.
127. van der Donk S, Buma P, Verdonschot N, Schreurs BW. Effect of load on the early incorporation of impacted morsellizedallografts. Biomaterials 2002;23:297-303.
128. Engh CA, Bobyn JD, Glassman AH. Porous-coated hipreplacement. The factors governing bone ingrowth, stressshielding, and clinical results. J Bone Joint Surg Br 1987;69:45-55.
129. Skoldenberg OG, Boden HS, Salemyr MO, Ahl TE, Adolphson PY. Periprosthetic proximal bone loss after uncemented hiparthroplasty is related to stem size: DXA measurements in 138patients followed for 2-7 years. Acta Orthop 2006;77:386-92.
130. Guldberg RE, Caldwell NJ, Guo XE, Goulet RW, Hollister SJ, Goldstein SA. Mechanical stimulation of tissue repair in thehydraulic bone chamber. J Bone Miner Res 1997;12:1295-302.
131. Little DG, Ramachandran M, Schindeler A. The anabolic andcatabolic responses in bone repair. JBone Joint SurgBr 2007;89-B:425-33.
132. Lind M, Overgaard S, Soballe K, Nguyen T, OngpipattanakulB, Bunger C. Transforming growth factor-beta 1 enhances bonehealing to unloaded tricalcium phosphate coated implants: anexperimental study in dogs. J Orthop Res 1996;14:343-50.
133. Lamberg A, Schmidmaier G, Soballe K, Elmengaard B. Locallydelivered TGF-beta1 and IGF-1 enhance the fixation of titaniumimplants: a study in dogs. Acta Orthop 2006;77:799-805.
134. Lamberg A, Bechtold JE, Baas J, Soballe K, Elmengaard B. Effect of local TGF-beta1 and IGF-1 release on implant fixation:comparison with hydroxyapatite coating: a paired study in dogs. Acta Orthop 2009;80:499-504.
135. Bobyn JD, Pilliar RM, Cameron HU, Weatherly GC. Theoptimum pore size for the fixation of porous-surfaced metalimplants by the ingrowth of bone. Clin Orthop Relat Res 1980:263-70.
136. Marie PJ. Strontium ranelate: a physiological approach foroptimizing bone formation and resorption. Bone 2006;38:S10-S4.
137. Marie PJ, Ammann P, Boivin G, Rey C. Mechanisms of actionand therapeutic potential of strontium in bone. CalcifTissue Int 2001;69:121-9.
138. Liao DP, Zhou ZY, Gu YF, Chen DM. [Experimental study ofmandibular reconstruction with Sr-HAP]. Shanghai KouQiangYiXue 2000;9:73-5.
139. Brewster NT, Gillespie WJ, Howie CR, Madabhushi SP, Usmani AS, Fairbairn DR. Mechanical considerations in impactionbone grafting. J Bone Joint Surg Br 1999;81:118-24.
140. Harris WH, Jackson RH, Jowsey J. The in vivo distribution oftetracyclines in canine bone. J Bone Joint Surg Am 1962;44-A:1308-20.
141. Sun TC, Mori S, Roper J, Brown C, Hooser T, Burr DB. Dodifferent fluorochrome labels give equivalent histomorphometricinformation? Bone 1992;13:443-6.
142. Lind M. Growth factor stimulation of bone healing. Effectson osteoblasts, osteomies, and implants fixation. Acta OrthopScand Suppl 1998;283:2-37.
143. Fleisch H. Bisphosphonates: mechanisms of action. EndocrRev 1998;19:80-100.
144. Pelker RR, Friedlaender GE, Markham TC, Panjabi MM, Moen CJ. Effects of freezing and freeze-drying on thebiomechanical properties of rat bone. JOrthopRes 1984;1:405-11.
145. Linde F, Sorensen HC. The effect of different storagemethods on the mechanical properties of trabecular bone. JBiomech 1993;26:1249-52.
146. Baas J. Adjuvant therapies of bone graft around noncementedexperimental orthopedic implants stereologicalmethods and experiments in dogs. Acta OrthopSuppl 2008;79:1-43.
147. Harrigan TP, Kareh J, Harris WH. The influence of supportconditions in the loading fixture on failure mechanisms in thepush-out test: a finite element study. J Orthop Res 1990;8:678-84.
148. Dhert WJ, Verheyen CC, Braak LH, de Wijn JR, Klein CP, de GK, et al. A finite element analysis of the push-out test: influenceof test conditions. JBiomedMaterRes 1992;26:119-30.
149. Erben RG. Embedding of bone samples inmethylmethacrylate: an improved method suitable for bonehistomorphometry, histochemistry, and immunohistochemistry. JHistochemCytochem 1997;45:307-13.
150. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, et al. Some new, simple and efficient stereologicalmethods and their use in pathological research and diagnosis. APMIS 1988;96:379-94.
151. Howard CRMG. Unbiased Stereology. Second ed: QTPPublications; 2005.
152. Overgaard S, Soballe K, Jorgen H, Gundersen G. Efficiency ofsystematic sampling in histomorphometric bone researchillustrated by hydroxyapatite-coated implants: optimizing thestereological vertical-section design. J Orthop Res 2000;18:313-21.
153. Gundersen HJ. Stereology: the fast lane betweenneuroanatomy and brain function--or still only a tightrope? ActaNeurol Scand Suppl 1992;137:8-13.
154. Limpert ES, W Abbt, M. Log-normal Distributions across theSciences: Keys and Clues. Bioscience 2001;51.
155. Gruner H. Thermal Spray Coatings on Titanium. In: BrunetteDT, P; Textor, M; Thomsen, Peter;, editor. Titanium in Medicine:material science, surface science, engineering, biologicalresponses and medical application. Berlin Heidelberg: Springer-Verlag; 2001. p. 375-416.
156. Li Y, Feng G, Gao Y, Luo E, Liu X, Hu J. Strontium ranelatetreatment enhances hydroxyapatite-coated titanium screwsfixation in osteoporotic rats. J Orthop Res 2010;28:578-82.
157. Vogel W. Glass Chemistry. Springer.
158. Gentleman E, Fredholm YC, Jell G, Lotfibakhshaiesh N, O'Donnell MD, Hill RG, et al. The effects of strontium-substitutedbioactive glasses on osteoblasts and osteoclasts in vitro. Biomaterials 2010;31:3949-56.